Brokerage firms covering shares of CRISPR Therapeutics AG (:CRSP) have given the stock a “Buy” rating on a consensus basis.  Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 2.50 on the shares.  Based on a recent trade, the shares are hovering around $38.64 which, according to analysts, yield significant upside potential to the $55.94 consensus target price.

With the stock market continuing to move higher, investors may be searching for stocks that are still fairly undervalued. This may involve doing a little bit more homework than usual. Spotting those names that have been cast aside and not garnering much recent attention might be a good place to start. Putting in a few extra hours of stock research may provide some good options for buying on the next big dip. Of course, nobody can say for sure how long the markets will continue to climb. Being ready for a pullback can help if investors already have some names in mind that they are looking to scoop up when they fall to a certain level. Tracking the technicals and staying up on the fundamentals should help investors hone in on the next wave of stocks to add to the portfolio.

Investors often have to make the decision of how aggressive they are going to invest. Some investors looking to make a quick dollar may jump in head first without a plan. This can be dangerous for the health of the portfolio in the long-term. Taking a chance on a risky stock may provide high returns, but investors often need to calculate whether the risk is worth the reward. Managing that risk in turbulent markets may help keep the average investor afloat when the markets inevitably turn sour for an extended period. Doing all the necessary stock research may include keeping a close tab on technicals, fundamentals, relevant economic data, and earnings reports. Investors may have to find a way to keep the rational side from being consumed by irrational behavior when studying the markets.  


CRISPR Therapeutics AG (:CRSP)’s shares may have a significant upside to the consensus target of 55.94, but how has it been performing relative to the market?  The stock’s price is 38.64 and their relative strength index (RSI) stands at 56.14.  RSI is a technical oscillator that shows price strength by comparing upward and downward movements.  It indicates oversold and overbought price levels for a stock.  

Trying to predict the day to day short-term movements of the stock market can be nearly impossible. Stocks have the tendency to make sudden moves on even the slightest bit of news or for apparently no reason at all. The daily trader may be looking to capitalize on swings or momentum, but the long-term investor may be searching for stability and consistency over a sustained period of time. During trading sessions, stock movements can seem like a popularity contest from time to time. Even after meticulous study, there may be no logical reason for a particular stock move. Riding out the waves of uncertainty may not be easy, but having a full-proof plan for when markets turn bad might be a great help to investors for long-term portfolio health.    

CRISPR Therapeutics AG (:CRSP) shares are moving 0.23% trading at $38.64 today.

The primary goal for some beginner traders might be just trying to survive. Traders that are disciplined with their money management may be able to better ride out the bumps that come with inexperience. Amateur traders tend to put too much at risk which can increase frustration during an extended losing streak. The more capital that is lost, the more difficult it can be to recover. Markets can be cruel, and traders that jump in without proper preparation can get pounded. Taking the time to carefully prepare before putting hard earned money at risk can help when the inevitable sticky situations arise.